These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 21218391)

  • 1. Intravitreal anti-VEGF bevacizumab (Avastin) for external beam related radiation retinopathy.
    Finger PT; Mukkamala SK
    Eur J Ophthalmol; 2011; 21(4):446-51. PubMed ID: 21218391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravitreal anti-VEGF therapy for macular radiation retinopathy: a 10-year study.
    Finger PT; Chin KJ; Semenova EA
    Eur J Ophthalmol; 2016; 26(1):60-6. PubMed ID: 26391167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose (2.0 mg) intravitreal ranibizumab for recalcitrant radiation retinopathy.
    Finger PT; Chin KJ
    Eur J Ophthalmol; 2013; 23(6):850-6. PubMed ID: 23813109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-vascular endothelial growth factor bevacizumab (avastin) for radiation retinopathy.
    Finger PT; Chin K
    Arch Ophthalmol; 2007 Jun; 125(6):751-6. PubMed ID: 17562985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The variable efficacy of intravitreal bevacizumab and triamcinolone acetonide for cystoid macular edema due to radiation retinopathy.
    Bakri SJ; Larson TA
    Semin Ophthalmol; 2015 Jul; 30(4):276-80. PubMed ID: 24251435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term effect of intravitreal bevacizumab (avastin) in patients with chronic diffuse diabetic macular edema.
    Kook D; Wolf A; Kreutzer T; Neubauer A; Strauss R; Ulbig M; Kampik A; Haritoglou C
    Retina; 2008 Oct; 28(8):1053-60. PubMed ID: 18779710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema.
    Haritoglou C; Kook D; Neubauer A; Wolf A; Priglinger S; Strauss R; Gandorfer A; Ulbig M; Kampik A
    Retina; 2006; 26(9):999-1005. PubMed ID: 17151486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of radiation maculopathy with intravitreal injection of bevacizumab (Avastin).
    Gupta A; Muecke JS
    Retina; 2008; 28(7):964-8. PubMed ID: 18698298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravitreal bevacizumab at 4-month intervals for prevention of macular edema after plaque radiotherapy of uveal melanoma.
    Shah SU; Shields CL; Bianciotto CG; Iturralde J; Al-Dahmash SA; Say EAT; Badal J; Mashayekhi A; Shields JA
    Ophthalmology; 2014 Jan; 121(1):269-275. PubMed ID: 24139123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
    Ding X; Li J; Hu X; Yu S; Pan J; Tang S
    Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT AT 2-MONTH INTERVALS REDUCES FOVEAL AVASCULAR ZONE ENLARGEMENT AND VISION LOSS IN RADIATION MACULOPATHY: A Pilot Study.
    Daruich A; Matet A; Schalenbourg A; Zografos L
    Retina; 2019 Aug; 39(8):1519-1526. PubMed ID: 29746413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravitreal triamcinolone acetate for radiation maculopathy recalcitrant to high-dose intravitreal bevacizumab.
    Kaplan RI; Chaugule SS; Finger PT
    Br J Ophthalmol; 2017 Dec; 101(12):1694-1698. PubMed ID: 28416492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravitreal bevacizumab for radiation-induced cystoid macular oedema in patients with nasopharyngeal carcinoma: a clinical series.
    Subrayan V; Khaw KW; Peyman M; Koay AC; Tajunisah I
    Ophthalmologica; 2013; 229(4):208-11. PubMed ID: 23548379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of two doses of intravitreal bevacizumab as primary treatment for macular edema secondary to central retinal vein occlusion: results of the pan American collaborative retina study group at 24 months.
    Wu L; Arevalo JF; Berrocal MH; Maia M; Roca JA; Morales-Cantón V; Alezzandrini AA; Díaz-Llopis MJ
    Retina; 2010; 30(7):1002-11. PubMed ID: 20616679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravitreal bevacizumab therapy on an as-per-needed basis in subfoveal choroidal neovascularization secondary to pathological myopia: 2-year outcomes of a prospective case series.
    Iacono P; Parodi MB; Papayannis A; Kontadakis S; Sheth S; Bandello F
    Retina; 2011 Oct; 31(9):1841-7. PubMed ID: 21775926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal bevacizumab treatment for radiation macular edema after plaque radiotherapy for choroidal melanoma.
    Mason JO; Albert MA; Persaud TO; Vail RS
    Retina; 2007 Sep; 27(7):903-7. PubMed ID: 17891015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monthly intravitreal bevacizumab for macular edema after iodine-125 plaque radiotherapy of uveal melanoma.
    Mashayekhi A; Rojanaporn D; Al-Dahmash S; Shields CL; Shields JA
    Eur J Ophthalmol; 2014; 24(2):228-34. PubMed ID: 23934823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Switching therapy from bevacizumab to aflibercept for the management of persistent diabetic macular edema.
    Bahrami B; Hong T; Zhu M; Schlub TE; Chang A
    Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1133-1140. PubMed ID: 28238195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One-year outcomes of less frequent bevacizumab in age-related macular degeneration.
    Sonmez K; Sonmez PA; Ozkan SS; Atmaca LS
    Retina; 2011 Apr; 31(4):645-53. PubMed ID: 21358363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of two doses of intravitreal bevacizumab as primary treatment for macular edema secondary to branch retinal vein occlusions: results of the Pan American Collaborative Retina Study Group at 24 months.
    Wu L; Arevalo JF; Berrocal MH; Maia M; Roca JA; Morales-Cantón V; Alezzandrini AA; Díaz-Llopis MJ
    Retina; 2009; 29(10):1396-403. PubMed ID: 19898177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.